10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever 0.0% of Sorrento Therapeutics shares are owned by institutional investors.

Stock analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the ...

Sorrento Therapeutics, Inc. (SRNEQ) announced today positive Phase 2a top-line clinical trial results for the RTX program.The Phase 2a study follows the positive ...

Shares in Sorrento Therapeutics rose 158% on Friday after it revealed plans to start human trials of an antibody therapy that achieved complete inhibition of the coronavirus in preclinical studies.

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any ...

Local biotech Aardvark Therapeutics made its debut on the public market this month, making it San Diego’s first life science ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.